What You Should Know:
- C2i Genomics, a cancer intelligence company, today announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical leader.
- The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers.
- Expanding on a completion of AstraZeneca’s accelerator BeyondBio SCALE program for start-ups and successful technology validation, C2i Genomics and AstraZeneca
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
The Patient Journey Tech Stack: 10 Pharma Predictions for 2023
The complexity of demands on Market Access teams has increased in recent years, between introducing innovative therapies targeting smaller populations and higher bars from Payers and PBMs.
Now, drug manufacturers are bucking up. According to the IQVIA Institute, the prescription abandonment rate has reached 27 percent, or $76 billion annually, in specialty drugs alone. This squandered revenue has led manufacturers to increase their focus on the complex, nuanced patient journey.
As a
Read More
The Evolution from Hearing Aids to Wellness Devices
Here’s what we know from decades of research: Hearing loss affects health and well-being, but people with hearing loss are often reluctant to wear hearing aids. Of course, they’re doing themselves no favors. But when they do finally opt for hearing assistance (on average, about seven years after they learn they need it), we also now know that the longer people wear hearing aids — throughout the day, for instance, rather than just in certain situations — the healthier they tend to be. Better
Read More
Real-World Study Uses AI to Identify Undiagnosed Dementia in Primary Care
What You Should Know:
- Rising to meet the formidable challenge of the timely diagnosis of dementia, research scientists from Regenstrief Institute, IUPUI and the medical schools of Indiana University and the University of Miami are conducting the Digital Detection of Dementia study, a real-world evaluation of the use of an artificial intelligence (AI) tool they developed for early identification of Alzheimer’s disease and related dementias in primary care, the setting where most adults
Read More
We’re Feeling the Effects of the Nursing Shortage. Health Tech Can Help
The healthcare industry is in desperate need of nurses — and fast. Chances are this isn't news to you. You've seen the countless headlines covering the impact the pandemic has had on nurses, and how that nursing shortage has impacted employment numbers, healthcare facilities, and patient care.
Nurses are burnt out. They're stressed, exhausted, and struggling to find adequate mental health support. But the pandemic isn't the only issue to blame. Experts are predicting that over 1 million RNs
Read More
Kahun Taps MediOrbis to Offer AI-Powered Digital Intake and Triage Services
What You Should Know:
- MediOrbis, a multi-specialty telehealth company today announces a strategic partnership with Kahun, the clinical reasoning tool that performs dynamic clinical assessments at scale.
- The strategic partnership will enable MediOrbis to offer Kahun’s proprietary AI-driven digital intake tool as a part of its comprehensive telehealth platform.
- By offering Kahun’s proprietary AI-driven digital intake tool as a part of its comprehensive
Read More
Merck Invests in Gesund, Launches Medical AI Platform on AWS
What You Should Know:
- Gesund, the company ensuring that medical artificial intelligence (AI) is safe and effective for all, today announced the securing of a strategic investment from Merck as well as a launch of a new commercial platform on Amazon Web Services Marketplace.
- While terms of the investment are not being disclosed, the news signals support for the company's approach as it launches a first of its kind commercial platform on Amazon Web Services Marketplace, immediately
Read More
Encouraging Health Literacy Through Member Advocacy
With the swift rise of digital health tools in the last two years, consumers have easier access to more health information than ever before. But for many, the proliferation of digital health tools has done very little to change their level of health literacy.
Consumers are still confused about their insurance benefits, the resources they can access, and their options for care management, among other things.
As just one example, new research found that 50% of health insurance
Read More
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
What You Should Know:
- Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis.
- Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More
Convenient Scapegoat: Why Hesitancy is Not the Cause of Low Vaccination Rates in Africa
At this year’s World Economic Forum in Davos, the topic of the COVID-19 pandemic and its destructive impact was central to many of the discussions that took place. Among them, was the issue of vaccine hesitancy around the world, especially in underdeveloped nations such as those in Africa. According to Africa CDC, as of September 2022, Africa, the second most-populated continent, has only vaccinated 21% of its people; an inadequate number In comparison to other populated countries such as India
Read More
